Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 8/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.35 |
| ▸ | C1S | P09871 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | F2R | P25116 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4692009 | 0.92 | DHFR (0.46) | DHFRPAX8SLC2A1C1SPIK3CD | |
| SCHEMBL4687900 | 0.90 | DHFR (0.48) | DHFRSLC2A1F2R | |
| Trifluoroacetic Acid SCHEMBL4690346 | 0.88 | DHFR (0.41) | DHFRPAX8SLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4694171 | 0.87 | DHFR (0.41) | DHFRPAX8SLC2A1DHODH | |
| Trifluoroacetic Acid SCHEMBL5396524 | 0.86 | DHFR (0.39) | DHFRPAX8SLC2A1C1SPDGFRB | |
| Trifluoroacetic Acid SCHEMBL4692041 | 0.86 | DHFR (0.41) | DHFRPAX8SLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4688116 | 0.86 | DHFR (0.41) | DHFRPAX8SLC2A1F2R | |
| Trifluoroacetic Acid SCHEMBL4690832 | 0.85 | DHFR (0.40) | DHFRPAX8SLC2A1 | |
| Trifluoroacetic Acid SCHEMBL4687967 | 0.85 | SLC2A1 (0.41) | DHFRPAX8SLC2A1DHODHFGFR1 | |
| Trifluoroacetic Acid SCHEMBL4688971 | 0.85 | DHFR (0.41) | DHFRPAX8SLC2A1PDGFRBFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1628979-B1 | DIAMINOPYRROLOQUINAZOLINES COMPOUNDS AS PROTEIN TYROSINE PHOSPHATASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2008-03-19 | — | — | EP | disclosed |
| US-20070270445-A1 | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors | BERTHEL STEVEN J | 2007-11-22 | — | — | US | disclosed |
| US-7262297-B2 | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20040235872-A1 | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors | BERTHEL STEVEN JOSEPH (US) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235872-A1 | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors | PTPN5, PPP5C, PTP4A2 | DHFR 289/4885PAX8 1715/4885SLC2A1 271/4885 |
| US-20070270445-A1 | Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors | PTPN5, DUSP15, PPP5C | DHFR 339/4885PAX8 2586/4885SLC2A1 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.